The COVID-19 infection in dialysis: are home-based renal replacement therapies a way to improve patient management? by Cozzolino, M. et al.
Vol.:(0123456789) 
Journal of Nephrology 
https://doi.org/10.1007/s40620-020-00784-3
EDITORIAL
The COVID‑19 infection in dialysis: are home‑based renal replacement 
therapies a way to improve patient management?
Mario Cozzolino1 · Giorgina Barbara Piccoli2,3 · Talat Alp Ikizler4 · Claudio Ronco5,6
 
© Italian Society of Nephrology 2020
The novel coronavirus initially called SARS-CoV-2 (Severe 
Acute Respiratory Syndrome Corona Virus 2), and subse-
quently renamed COVID-19 (Corona Virus Disease 2019) 
was identified in Wuhan, China in December 2019. Since 
then, it has spread worldwide, and in some countries it has 
had an exponential, and initially unexpected, impact. It was 
declared a pandemic in March 2020 by the World Health 
Organization. The elderly and patients with comorbid con-
ditions such as hypertension, heart disease, diabetes, lung 
disease, and immunologic disorders were soon identified as 
being at risk of contracting a severe infection [1].
Various measures of containment were undertaken to 
prevent the spread of COVID-19, initially without in-depth 
knowledge of the clinical and epidemiological character-
istics of the virus. Patients with advanced chronic kidney 
disease (CKD), in particular, those on dialysis are a vulner-
able population and a challenge in the prevention and control 
of the disease. As the virus is transmitted through droplets 
and contact, treatments that need to be performed in limited, 
dedicated spaces require special care; hemodialysis units can 
be taken as the prototype of such settings [2, 3].
In northern Italy, we were the first in Europe to have 
to cope with the need to continue to manage our chronic 
dialysis patients while continuously adapting to the rapidly 
evolving emergency situation. Hundreds of patients were 
diagnosed as affected by COVID-19 in Italy’s northern 
regions, where the pandemic first hit, and the figures are 
probably underestimated, due to the low availability of tests, 
especially during the first phase of the epidemic. For exam-
ple, in two of the of the largest renal units in Milan, near 
the epicenter of the Italian epidemic, where 330 hemodialy-
sis (HD) patients and 50 peritoneal dialysis (PD) patients 
are followed, we tried to reduce exposure and the risk of 
contagion by decreasing the number of patients per shift 
in order to provide safe distance between patients during 
hemodialysis. To do so, we rapidly equipped additional 
treatment space with ten hemodialysis stations and added 
dialysis shifts. However, this led to staff shortages, which 
were already critical as members of the health care team had 
been infected. Although new stations were added, treatment 
time had to be shortened wherever clinically possible. In 
our Unit, 20 HD and 1 PD patient were diagnosed as having 
COVID-19 and 5 died.
Peritoneal dialysis patients were relatively spared and the 
advantages of this technique rapidly became evident, as did 
the importance of monitoring [4, 5].
Now that the epidemic is reaching a plateau, it is time to 
reflect on the lessons that could, and probably should trans-
form our models of delivering dialysis. Outpatient, thrice-
weekly hemodialysis is the standard of care in most coun-
tries, including Italy; dialysis delivery is often, probably too 
often, performed in a standardized way, and the population 
of mainly elderly and high-comorbidity patients often pas-
sively receives this intrusive, albeit life-sustaining treatment.
Under the pressure of need, we were obliged to tailor 
hemodialysis sessions to mediate between logistics and 
clinical priorities. This mediation further highlights how an 
incremental dialysis strategy, based on number of sessions 
as well as their duration, can be safe and patient-friendly 
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for many subjects with some residual kidney function [6]. 
During an epidemic incremental approaches play an impor-
tant role in limiting exposure; implementing the lessons in 
times of less pressure could lead to a personalized approach 
that limits morbidity, respects residual kidney function and 
minimizes iatrogenic impact. However, tailoring dialysis 
can be time consuming, and requires frequent monitoring. 
If on the one hand this could be seen as too demanding for 
overcrowded dialysis wards, the spare time for the patient 
and cost for the society could theoretically be reinvested in 
dedicated physician’s time (Table 1).
The issue of personalized incremental dialysis is intrin-
sically linked with home dialysis, in both HD and PD. The 
present epidemic has highlighted some of the limits of stand-
ard, thrice-weekly outpatient hemodialysis: it lacks flexibil-
ity, and large units are often preferred, given their economies 
of scale [7, 8].
Home-based renal replacement therapies have many 
advantages in this regard. First of all, they offer the oppor-
tunity to manage patients remotely, thus reducing contagion 
during an epidemic. The French health council, as well as 
some patients’ associations, recently underlined the impor-
tance of developing home dialysis choices to respond to 
the COVID crisis. Home dialysis involves making patients 
responsible for their own care and patient empowerment 
facilitates personalization of treatment. In this regard, the 
Advancing American Kidney Health Initiative (AAKHI) 
underlines that home dialysis should be promoted as an 
opportunity for patients to be engaged in their own treat-
ment. Flexibility applies not only to dialysis itself, but also 
to diet and, more widely, to lifestyle. The list of advantages 
of home dialysis is long and encompasses better preservation 
of residual kidney function, at least in PD and incremental 
hemodialysis, saving time, limiting travel from center to 
home and vice versa, lower costs (this issue is somewhat 
controversial), and possibly a smaller carbon footprint [9].
Home dialysis is however underdeveloped, for clini-
cal, cultural and economic reasons [8]. In-hospital dialy-
sis is often seen as simpler for the nursing staff and less 
demanding for the patient; since it is standardized it is also 
thought to reduce the physician’s involvement. Are these 
real advantages?
To face this crisis, many dialysis physicians had to invent 
solutions overnight, and, overall, succeeded in doing so.
The same flexibility and innovation should be applied to 
an in-depth revision of our practice, promoting home-based 
therapies: tailormade schedules, assisted home dialysis, 
strict telemonitoring, and home visits can be combined to 
make home dialysis possible and often preferable for fragile 
patients. This may not be simple, but it is certainly feasible 
(Table 1).
In summary, as we endure this unprecedented catastro-
phe, we should try to learn from it to improve the care of our 
vulnerable population. Considering the efficacy of lockdown 
in preventing the spread of the infection, home dialysis rep-
resents an ideal approach in the case of epidemics. It is a 
good opportunity for us to reconsider its value, and develop 
new approaches to make home and personalized treatments 
more widely available, as a strategic reinvestment not only in 
these times of crisis, but, even more importantly, in calmer 
times to come, hopefully soon.
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